Dosidal · Switzerland

Gaviscon Dual Liquid, Suspension zum Einnehmen in Sachets

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:67378 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 67378
atc: A02AX
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2021-01-22
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: A02AX
authorisation_number: 67378
form: SUORB
holder: Reckitt Benckiser (Switzerland) AG
holder_partner_nr: 1002083
it_number: 04.01.0.
name: Gaviscon Dual Liquid, Suspension zum Einnehmen in Sachets
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
gFn1lpNhD_dRCqZ1XHAoAtDGDvgJF_sCoCmD4A_xJAaxzvLU1pkwEuDdb7_Mi-kygNZISvzWOVeGrUAVN1T0SQ
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:67378 · Related records in other markets · Dosidal